共 163 条
[1]
Wijns W(2010)Guidelines on myocardial revascularization Eur Heart J 31 2501-2555
[2]
Kolh P(2010)Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial J Thromb Haemost 8 243-249
[3]
Danchin N(2008)Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2218-2230
[4]
Di Mario C(2015)Bivalirudin or unfractionated heparin in acute coronary syndromes N Engl J Med 373 997-1009
[5]
Falk V(2010)Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Lancet 375 283-293
[6]
Folliguet T(2012)Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 9-19
[7]
Anderson JA(2013)Bivalirudin started during emergency transport for primary PCI N Engl J Med 369 2207-2217
[8]
Hirsh J(2015)Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial JAMA 313 1336-1346
[9]
Yusuf S(2014)Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial Lancet 384 1849-1858
[10]
Johnston M(2011)Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction N Engl J Med 365 1980-1989